List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1260 studies with search of: lymphoma [CONDITION] OR CLL [CONDITION] | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Conditions: Hematopoietic/Lymphoid Cancer;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large-Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   B-cell Chronic Lymphocytic Leukemia;   Burkitt Lymphoma;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Lymphoma, Mucosa-Associated Lymphoid Tissue;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Peripheral T-Cell Lymphoma;   Prolymphocytic Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Multiple Myeloma;   Splenic Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions: Drug: carmustine;   Drug: etoposide;   Drug: cytarabine;   Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Drug: tacrolimus;   Drug: mycophenolate mofetil;   Radiation: total-body irradiation;   Drug: melphalan;   Procedure: autologous-allogeneic tandem hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: allogeneic bone marrow transplantation;   Other: fluorescence in situ hybridization;   Other: flow cytometry;   Other: RNA analysis;   Other: laboratory biomarker analysis;   Other: cytogenetic analysis;   Other: polymerase chain reaction
2 Recruiting Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL;   Lymphoma, Non-Hodgkin;   Lymphoma, B-Cell;   Lymphoma, Follicular;   Lymphoma, Intermediate-Grade;   Lymphoma, Large-Cell;   Lymphoma, Low-Grade;   Lymphoma, Mixed-Cell;   Lymphoma, Small-Cell;   Leukemia, Lymphocytic, Chronic;   Leukemia, B-Cell, Chronic;   Leukemia, Prolymphocytic;   Leukemia, Small Lymphocytic;   Lymphoma, Small Lymphocytic;   Lymphoma, Lymphoplasmacytoid, CLL;   Lymphoplasmacytoid Lymphoma, CLL;   CLL;   SLL
Intervention: Biological: veltuzumab
3 Recruiting Phase I/II Study of B Cell Malignancies Using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prior to T Cell Transfer
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma;   Large Cell Lymphoma
Interventions: Genetic: Anti-CD19-CAR Transduced PBL;   Drug: Aldesleukin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: PG13-CD19-H3 (anti-CD19-CAR) transduced PBL)
4 Recruiting Study of MLN8237 in Patients With Advanced Hematological Malignancies
Conditions: B-cell Follicular Lymphoma;   B-cell Marginal Zone Lymphoma;   Diffuse Large B-cell Lymphoma;   B-cell Mantle Cell Lymphoma;   B-cell Small Lymphocytic Lymphoma (SLL);   B-Cell Chronic Lymphocytic Leukemia (B-CLL);   Multiple Myeloma;   Waldenstrom's Macroglobulinemia
Intervention: Drug: MLN8237
5 Recruiting Study of AMD3100 and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia (CLL);   Small Lymphocytic Lymphoma (SLL)
Intervention: Drug: Plerixafor
6 Recruiting Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma
Conditions: Acute Lymphocytic Leukemia;   Follicular Lymphoma;   Chronic Lymphocytic Leukemia (CLL);   Mantle Cell Lymphoma;   Prolymphocytic Leukemia;   Large Cell Lymphoma
Intervention: Biological: CART-19
7 Recruiting Study Looking at Effectiveness of 131-Tositumomab (Bexxar) Consolidation for Patients With CLL or SLL
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Intervention: Drug: 131TOSITUMOMAB (BEXXAR®)
8 Recruiting Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Non-Hodgkin's Lymphoma (Follicular, Diffuse Large Cell, Mantle Cell, and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Diffuse Large Cell Lymphoma;   Mantle Cell Lymphoma;   Small Lymphocytic Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35
9 Recruiting A Phase I/II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituxamib, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Conditions: Follicular Lymphoma (Grade I, II, III);   B-Cell Small Lymphocytic Lymphoma;   Chronic Lymphocytic Leukemia;   Marginal Zone Lymphoma;   Waldenstrom's Macroglobulinemia;   Mantle Cell Lymphoma
Intervention: Drug: Bortezomib
10 Recruiting Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
Conditions: Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma;   Chronic Lymphocytic Leukemia;   CML;   AML;   ALL;   MDS;   NHL;   CLL
Intervention: Biological: CD3/CD28 Activated T cells
11 Recruiting Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
Conditions: Chronic Lymphocytic Leukemia (CLL);   Lymphoma, Non-Hodgkin (NHL);   Acute Myeloid Leukemia (AML)
Intervention: Drug: CAL-101
12 Recruiting First-Line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
Conditions: Follicular Lymphoma;   Marginal Zone Lymphoma;   Small Lymphocytic Lymphoma;   Lymphoplasmacytic Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Vincristine, Prednisone;   Drug: Rituximab, Cyclophosphamid, Doxorubicin, Vincristine, Prednisone
13 Recruiting Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain
Conditions: Chronic Lymphocytic Leukemia (B-CLL);   B Cell Non-Hodgkin Lymphoma (B-NHL)
Intervention: Biological: Genetically modified T cells
14 Recruiting A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia;   Multiple Myeloma
Intervention: Drug: GS-9219
15 Recruiting Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemias;   Multiple Myeloma With Plasmacytoma
Interventions: Procedure: Single fraction radiation (8-Gy);   Procedure: Donor Lymphocyte Infusion
16 Recruiting Host Dendritic Cells in Allograft Patients
Conditions: Relapsed Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma;   Chronic Lymphocytic Lymphoma
Intervention: Biological: MSSM/BIIR HDC Vax-001 (Host Dendritic Cells)
17 Recruiting Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
Conditions: Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplasia;   Lymphoma, Non-Hodgkin;   Hodgkin's Lymphoma;   Multiple Myeloma
Intervention: Drug: Clioquinol
18 Recruiting Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in NHL/CLL
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Lymphoma
Intervention: Biological: milatuzumab
19 Recruiting Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Leukemia;   Lymphoma
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Biological: graft-versus-tumor induction therapy;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Radiation: total-body irradiation
20 Recruiting Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia;   Non-Hodgkin's Lymphoma
Interventions: Drug: bendamustine and lenalidomide;   Drug: BL-NHL;   Drug: BLR-CLL;   Drug: BLR-NHL

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services